We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood and Laboratory Solutions Licensed by German University

By LabMedica International staff writers
Posted on 22 Apr 2009
Print article
A German University clinic has licensed a blood information system and laboratory information system for its blood center.

EdgeBlood is the leading Blood Center management system used in France. It is also used to process more than half the blood drawn in Germany as well as processing significant parts of the Austrian and Swiss blood supplies. EdgeBlood is used in Greece as well as five African countries. EdgeBlood has an easy-to-use Windows graphical user interface and contains all major functionality needed by a blood center from donor recruitment through product distribution.

EdgeLab has become the leading Laboratory Information Management System (LIMS) in Europe and is used in more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software packages. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality. EdgeLab can be easily configured to meet the business needs of large, diverse, multisite hospital laboratories, as well as small, single site hospitals.

GLI (Alzey, Germany) is the German division of Global Med Technology's Inlog subsidiary. The two systems, EdgeBlood and EdgeLab, have been licensed by the University of Saarland Clinic Blood Center (Homburg, Germany) from GLI. The systems will be deployed on 25 workstations in the blood center and laboratory. Up to 50 remote users will access the Web result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's Laboratory Information System. The blood center collects 30,000 whole blood donations per year.

"After detailed market research, the University Medical Center of Saarland has decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This decision was made because, among other reasons, the system can completely control the management of all essential services in transfusion medicine. Moreover, the software is already in use in the National German Red Cross Blood Donation Services. It has also been used successfully in comparable university facilities for many years. In view of the connection between pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and EdgeLab will create a center of excellence for the University Medical Center of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical Center of Saarland.

Related Links:

GLI
University of Saarland Clinic Blood Center


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Multi-Function Pipetting Platform
apricot PP5

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.